ATAI Life Sciences NV Defensive Interval Ratio
ATAI Life Sciences NV defensive interval ratio. ATAI Life Sciences NV (9VC) has a Defensive Interval Ratio of 1858 days as of September 2025. Defensive assets of €84.20 Million (cash €-, short-term investments €84.20 Million, receivables €-) cover 1858 days of daily cash needs of €45.33K/day. See 9VC net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Defensive Interval Ratio of ATAI Life Sciences NV (2021–2024)
Defensive interval ratio of ATAI Life Sciences NV from 2021 to 2024. This chart shows how ATAI Life Sciences NV's Defensive Interval Ratio has evolved across 4 annual periods from 2021 to 2024. As of September 2025, the ratio stands at 1858 days, meaning defensive assets of €84.20 Million can fund 1858 days of operations without new revenue. Check ATAI Life Sciences NV (9VC) asset resilience to evaluate the company's liquid asset resilience ratio.
ATAI Life Sciences NV Defensive Interval Ratio by Year (2021–2024)
ATAI Life Sciences NV defensive interval ratio by year from 2021 to 2024. The table below presents the year-by-year Defensive Interval Ratio for ATAI Life Sciences NV from 2021 to 2024, covering 4 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For the complete balance sheet picture, see total assets of ATAI Life Sciences NV.
| Year | DIR (days) | Defensive Assets (EUR) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2024 | 656 days | €44.83 Million | €68.36K/day | €- | €44.83 Million | ▼ -1779 days |
| 2023 | 2435 days | €134.22 Million | €55.12K/day | €- | €134.22 Million | ▲ +922 days |
| 2022 | 1513 days | €82.50 Million | €54.51K/day | €- | €82.50 Million | ▲ +1513 days |
| 2021 | 0 days | €0.00 | €57.36K/day | €- | €0.00 | — |